The Research Desk tracks what's actually moving in the peptide evidence base. New human trials, systematic reviews, negative results, and myth-checks on claims that keep circulating despite the data.
Status: forthcoming
The Research Desk launches alongside the weekly The Peptide Addict Intel newsletter. The first Research Briefs cover the most-cited claims in the peptide conversation and assess them against the actual published evidence.
What to expect
Each Research Brief follows the same structure:
- The finding in one sentence — what the study or paper actually says
- What the study looked at — design, population, intervention, outcome measures
- What it does and does not prove — the honest scope of the conclusions
- How it changes the current picture — if it does
- Bottom line — the plain-English takeaway
We read:
- PubMed and Google Scholar (for new trials and reviews)
- Clinical trial registries (for studies in progress)
- Review journals in obesity, endocrinology, sports medicine, wound healing, longevity, and neuroscience
- Peer-reviewed case reports where they represent new information
Foundational reading
- The Beginner's Guide to Peptides — the frame the Research Desk operates inside.
- Methodology — the evidence ladder we use to rank claims.
- Editorial Policy — the principles that govern what we publish.